House Bill 220
116th Congress(2019-2020)
National Lyme and Tick-Borne Diseases Control and Accountability Act of 2019
Introduced
Introduced in House on Jan 3, 2019
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
220
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Chris Smith
grade
New Jersey
California
Florida
Indiana
Maine
Minnesota
Missouri
New Hampshire
New Jersey
New Jersey
New York
New York
New York
New York
New York
New York
New York
New York
New York
Pennsylvania
Pennsylvania
Texas
No House votes have been held for this bill.
Summary
National Lyme and Tick-Borne Diseases Control and Accountability Act of 2019
This bill establishes the Office of Oversight and Coordination for Tick-Borne Diseases within the Department of Health and Human Services (HHS). The office must oversee the creation of a national strategy to address Lyme disease and other tick-borne diseases and disorders. The national strategy must include program assessments, benchmarks for progress, and recommendations from the previously established Tick-Borne Disease Working Group.
The bill also requires HHS to undertake specific actions that promote research, prevention, and treatment of Lyme disease and other tick-borne diseases and disorders. Among other things, HHS must:
- support expansive research into the pathology, diagnosis, and treatment of such diseases and disorders;
- establish a surveillance system to track the prevalence of such diseases and disorders in humans;
- establish a surveillance system to track the prevalence of disease-carrying ticks;
- conduct educational campaigns; and
- hold a series of research symposiums.
January 3, 2019
01/25/2019
Referred to the Subcommittee on Health.
01/03/2019
Referred to the House Committee on Energy and Commerce.
01/03/2019
Introduced in House
Public Record
Record Updated
Nov 1, 2022 1:49:27 PM